| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS12 PRSS53 ADAMTS9 PRSS12 CELA2A ADAMTS20 ADAMTS8 CELA2B BACE2 ESPL1 | 4.06e-06 | 430 | 74 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 7.00e-05 | 188 | 74 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS12 PRSS53 ADAMTS9 PRSS12 CELA2A ADAMTS20 ADAMTS8 CELA2B BACE2 ESPL1 | 1.44e-04 | 654 | 74 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | N-acylsphingosine amidohydrolase activity | 2.81e-04 | 7 | 74 | 2 | GO:0017040 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 3.74e-04 | 8 | 74 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 7.29e-04 | 11 | 74 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.03e-03 | 120 | 74 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 1.38e-03 | 15 | 74 | 2 | GO:0008020 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS12 THSD4 QSOX1 ADAMTS9 ADAMTS20 PAPLN ADAMTS8 ADAMTSL3 | 6.71e-05 | 377 | 75 | 8 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS12 THSD4 QSOX1 ADAMTS9 ADAMTS20 PAPLN ADAMTS8 ADAMTSL3 | 6.84e-05 | 378 | 75 | 8 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS12 THSD4 QSOX1 ADAMTS9 ADAMTS20 PAPLN ADAMTS8 ADAMTSL3 | 6.96e-05 | 379 | 75 | 8 | GO:0045229 |
| GeneOntologyBiologicalProcess | ceramide catabolic process | 1.13e-04 | 26 | 75 | 3 | GO:0046514 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 1.30e-04 | 5 | 75 | 2 | GO:0045636 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS12 THSD4 FCGBP VWF ADAMTS9 SPON1 CELA2A ADAMTS20 PAPLN ADAMTS8 CELA2B DMBT1 ADAMTSL3 MARCO FGL2 | 1.16e-08 | 656 | 76 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS12 THSD4 FCGBP VWF ADAMTS9 SPON1 CELA2A ADAMTS20 PAPLN ADAMTS8 CELA2B DMBT1 ADAMTSL3 MARCO FGL2 | 1.21e-08 | 658 | 76 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | THSD4 VWF ADAMTS9 SPON1 CELA2A ADAMTS20 PAPLN ADAMTS8 CELA2B DMBT1 MARCO FGL2 | 4.42e-07 | 530 | 76 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | keratohyalin granule | 1.30e-04 | 5 | 76 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | membrane attack complex | 2.71e-04 | 7 | 76 | 2 | GO:0005579 | |
| MousePheno | abnormal parasympathetic nervous system physiology | 1.29e-07 | 11 | 64 | 4 | MP:0006277 | |
| MousePheno | abnormal postsynaptic density morphology | 6.48e-06 | 27 | 64 | 4 | MP:0020551 | |
| MousePheno | abnormal asymmetric synapse morphology | 7.53e-06 | 28 | 64 | 4 | MP:0020360 | |
| MousePheno | abnormal autonomic nervous system physiology | 4.31e-05 | 43 | 64 | 4 | MP:0006276 | |
| Domain | TSP_1 | ADAMTS12 THSD4 UNC5A SEMA5B ADAMTS9 SPON1 ISM1 ADGRB1 ADGRB3 ADAMTS20 PAPLN ADAMTS8 C6 C8A ADAMTSL3 | 1.73e-23 | 63 | 73 | 15 | PF00090 |
| Domain | TSP1 | ADAMTS12 THSD4 UNC5A SEMA5B ADAMTS9 SPON1 ISM1 ADGRB1 ADGRB3 ADAMTS20 PAPLN ADAMTS8 C6 C8A ADAMTSL3 | 2.92e-23 | 65 | 73 | 15 | SM00209 |
| Domain | TSP1_rpt | ADAMTS12 THSD4 UNC5A SEMA5B ADAMTS9 SPON1 ISM1 ADGRB1 ADGRB3 ADAMTS20 PAPLN ADAMTS8 C6 C8A ADAMTSL3 | 2.92e-23 | 65 | 73 | 15 | IPR000884 |
| Domain | TSP1 | ADAMTS12 THSD4 UNC5A SEMA5B ADAMTS9 SPON1 ISM1 ADGRB1 ADGRB3 ADAMTS20 PAPLN ADAMTS8 C6 C8A ADAMTSL3 | 2.92e-23 | 65 | 73 | 15 | PS50092 |
| Domain | ADAM_spacer1 | 2.77e-10 | 23 | 73 | 6 | IPR010294 | |
| Domain | ADAM_spacer1 | 2.77e-10 | 23 | 73 | 6 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 3.68e-10 | 24 | 73 | 6 | IPR013273 | |
| Domain | PLAC | 7.96e-07 | 19 | 73 | 4 | PS50900 | |
| Domain | PLAC | 7.96e-07 | 19 | 73 | 4 | IPR010909 | |
| Domain | Ceramidse_alk_C | 1.51e-05 | 2 | 73 | 2 | PF17048 | |
| Domain | Pept_M12B_GON-ADAMTSs | 1.51e-05 | 2 | 73 | 2 | IPR012314 | |
| Domain | GON | 1.51e-05 | 2 | 73 | 2 | PF08685 | |
| Domain | NEUT/ALK_ceramidase_C | 1.51e-05 | 2 | 73 | 2 | IPR031331 | |
| Domain | GON | 1.51e-05 | 2 | 73 | 2 | PS51046 | |
| Domain | Ceramidase_alk | 1.51e-05 | 2 | 73 | 2 | IPR006823 | |
| Domain | Peptidase_M12B_N | 1.59e-05 | 39 | 73 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.59e-05 | 39 | 73 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.76e-05 | 40 | 73 | 4 | PS00427 | |
| Domain | Reprolysin | 1.76e-05 | 40 | 73 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 1.76e-05 | 40 | 73 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.76e-05 | 40 | 73 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 1.76e-05 | 40 | 73 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 1.95e-05 | 41 | 73 | 4 | IPR001762 | |
| Domain | PLAC | 2.02e-05 | 14 | 73 | 3 | PF08686 | |
| Domain | GPCR_2_brain_angio_inhib | 4.51e-05 | 3 | 73 | 2 | IPR008077 | |
| Domain | SRCR | 7.24e-05 | 21 | 73 | 3 | PF00530 | |
| Domain | SR | 1.24e-04 | 25 | 73 | 3 | SM00202 | |
| Domain | - | 1.24e-04 | 25 | 73 | 3 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.40e-04 | 26 | 73 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.40e-04 | 26 | 73 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 1.40e-04 | 26 | 73 | 3 | IPR017448 | |
| Domain | SRCR | 1.57e-04 | 27 | 73 | 3 | IPR001190 | |
| Domain | MACPF_CS | 2.24e-04 | 6 | 73 | 2 | IPR020863 | |
| Domain | MetalloPept_cat_dom | 2.85e-04 | 81 | 73 | 4 | IPR024079 | |
| Domain | - | 2.85e-04 | 81 | 73 | 4 | 3.40.390.10 | |
| Domain | MACPF_2 | 3.12e-04 | 7 | 73 | 2 | PS51412 | |
| Domain | MACPF_1 | 3.12e-04 | 7 | 73 | 2 | PS00279 | |
| Domain | TRYPSIN_SER | 4.26e-04 | 90 | 73 | 4 | IPR033116 | |
| Domain | ZINC_PROTEASE | 5.88e-04 | 98 | 73 | 4 | PS00142 | |
| Domain | MAC_perforin | 6.64e-04 | 10 | 73 | 2 | IPR001862 | |
| Domain | F-box-like | 6.76e-04 | 44 | 73 | 3 | PF12937 | |
| Domain | TRYPSIN_HIS | 7.09e-04 | 103 | 73 | 4 | IPR018114 | |
| Domain | TRYPSIN_SER | 7.90e-04 | 106 | 73 | 4 | PS00135 | |
| Domain | MACPF | 8.10e-04 | 11 | 73 | 2 | PF01823 | |
| Domain | GAIN_dom_N | 8.10e-04 | 11 | 73 | 2 | IPR032471 | |
| Domain | GAIN | 8.10e-04 | 11 | 73 | 2 | PF16489 | |
| Domain | TRYPSIN_HIS | 8.18e-04 | 107 | 73 | 4 | PS00134 | |
| Domain | TIL | 9.70e-04 | 12 | 73 | 2 | PF01826 | |
| Domain | MACPF | 9.70e-04 | 12 | 73 | 2 | SM00457 | |
| Domain | MACPF | 9.70e-04 | 12 | 73 | 2 | IPR020864 | |
| Domain | C8 | 9.70e-04 | 12 | 73 | 2 | PF08742 | |
| Domain | Peptidase_S1A | 1.00e-03 | 113 | 73 | 4 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.07e-03 | 115 | 73 | 4 | PS50240 | |
| Domain | FBOX | 1.10e-03 | 52 | 73 | 3 | SM00256 | |
| Domain | Tryp_SPc | 1.14e-03 | 117 | 73 | 4 | SM00020 | |
| Domain | Unchr_dom_Cys-rich | 1.14e-03 | 13 | 73 | 2 | IPR014853 | |
| Domain | C8 | 1.14e-03 | 13 | 73 | 2 | SM00832 | |
| Domain | CUB | 1.17e-03 | 53 | 73 | 3 | PS01180 | |
| Domain | Trypsin | 1.29e-03 | 121 | 73 | 4 | PF00089 | |
| Domain | Trypsin_dom | 1.29e-03 | 121 | 73 | 4 | IPR001254 | |
| Domain | TIL_dom | 1.33e-03 | 14 | 73 | 2 | IPR002919 | |
| Domain | Peptidase_S1_PA | 1.37e-03 | 123 | 73 | 4 | IPR009003 | |
| Domain | CUB_dom | 1.44e-03 | 57 | 73 | 3 | IPR000859 | |
| Domain | VWD | 1.75e-03 | 16 | 73 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.75e-03 | 16 | 73 | 2 | IPR001846 | |
| Domain | VWFD | 1.75e-03 | 16 | 73 | 2 | PS51233 | |
| Domain | VWD | 1.75e-03 | 16 | 73 | 2 | PF00094 | |
| Domain | AMP-bd_C | 1.97e-03 | 17 | 73 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.97e-03 | 17 | 73 | 2 | PF13193 | |
| Domain | F-box | 2.29e-03 | 67 | 73 | 3 | PF00646 | |
| Domain | VWC_out | 2.47e-03 | 19 | 73 | 2 | SM00215 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 2.47e-03 | 19 | 73 | 2 | IPR006553 | |
| Domain | LRR_CC | 2.47e-03 | 19 | 73 | 2 | SM00367 | |
| Domain | FBOX | 2.82e-03 | 72 | 73 | 3 | PS50181 | |
| Domain | F-box_dom | 3.16e-03 | 75 | 73 | 3 | IPR001810 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 4.23e-12 | 39 | 61 | 8 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 4.23e-12 | 39 | 61 | 8 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 4.61e-10 | 68 | 61 | 8 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 2.07e-08 | 109 | 61 | 8 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 2.38e-08 | 111 | 61 | 8 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 ADAMTSL3 | 1.72e-07 | 143 | 61 | 8 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS12 THSD4 SEMA5B ADAMTS9 SPON1 ADAMTS20 ADAMTS8 LCT ADAMTSL3 | 1.17e-06 | 250 | 61 | 9 | M27554 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 THSD4 QSOX1 TRIM25 SEMA5B ADAMTS9 SPON1 ADAMTS20 WSB2 FBXW2 ADAMTS8 HERC2 ADAMTSL3 SKP2 FBXL5 TTLL7 SEC13 | 1.19e-04 | 1475 | 61 | 17 | M19806 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 THSD4 QSOX1 SEMA5B ADAMTS9 SPON1 ADAMTS20 WSB2 FBXW2 ADAMTS8 HERC2 ADAMTSL3 SKP2 FBXL5 TTLL7 SEC13 | 2.01e-04 | 1389 | 61 | 16 | MM15307 |
| Pathway | BIOCARTA_PEPI_PATHWAY | 3.81e-04 | 7 | 61 | 2 | MM1589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 3.81e-04 | 7 | 61 | 2 | M47873 | |
| Pathway | BIOCARTA_PEPI_PATHWAY | 5.07e-04 | 8 | 61 | 2 | M22084 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 5.07e-04 | 8 | 61 | 2 | M27006 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 5.07e-04 | 8 | 61 | 2 | MM14656 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 6.50e-04 | 9 | 61 | 2 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 6.50e-04 | 9 | 61 | 2 | M47881 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 1.18e-03 | 12 | 61 | 2 | M48316 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.39e-03 | 13 | 61 | 2 | M4732 | |
| Pubmed | ADAMTS12 THSD4 UNC5A SEMA5B ADAMTS9 SPON1 ISM1 ADGRB1 ADGRB3 ADAMTS20 PAPLN ADAMTS8 C6 ADAMTSL3 | 8.03e-24 | 75 | 76 | 14 | 20637190 | |
| Pubmed | 6.87e-09 | 11 | 76 | 4 | 33909046 | ||
| Pubmed | 1.63e-06 | 11 | 76 | 3 | 22975506 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 2.17e-06 | 12 | 76 | 3 | 25770910 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10652340 | ||
| Pubmed | Neutral ceramidase gene: role in regulating ceramide-induced apoptosis. | 4.71e-06 | 2 | 76 | 2 | 14557071 | |
| Pubmed | Genomic structure and promoter analysis of the mouse neutral ceramidase gene. | 4.71e-06 | 2 | 76 | 2 | 12435403 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19734141 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11328816 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 35354041 | ||
| Pubmed | Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. | 4.71e-06 | 2 | 76 | 2 | 18801734 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16126722 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 28386233 | ||
| Pubmed | Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. | 4.71e-06 | 2 | 76 | 2 | 19345744 | |
| Pubmed | Lactosylceramide contributes to mitochondrial dysfunction in diabetes. | 4.71e-06 | 2 | 76 | 2 | 26900161 | |
| Pubmed | Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans. | 4.71e-06 | 2 | 76 | 2 | 16327289 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 15361761 | ||
| Pubmed | Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease. | 4.71e-06 | 2 | 76 | 2 | 22940715 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 24659784 | ||
| Pubmed | A novel gene derived from a segmental duplication shows perturbed expression in Alzheimer's disease. | 4.71e-06 | 2 | 76 | 2 | 17334805 | |
| Pubmed | Loss of neutral ceramidase protects cells from nutrient- and energy -deprivation-induced cell death. | 4.71e-06 | 2 | 76 | 2 | 26747710 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 11470804 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 21613224 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 12514189 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 10753931 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 3646943 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 19724244 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 16380386 | ||
| Pubmed | Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury. | 4.71e-06 | 2 | 76 | 2 | 35151662 | |
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 37944753 | ||
| Pubmed | 4.71e-06 | 2 | 76 | 2 | 27609772 | ||
| Pubmed | 1.11e-05 | 20 | 76 | 3 | 19922873 | ||
| Pubmed | 1.21e-05 | 64 | 76 | 4 | 22261194 | ||
| Pubmed | The molecular circuitry regulating the switch between iron deficiency and overload in mice. | 1.41e-05 | 3 | 76 | 2 | 16418170 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 38302493 | ||
| Pubmed | Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α. | 1.41e-05 | 3 | 76 | 2 | 35871160 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 24753090 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 20803549 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 18955860 | ||
| Pubmed | Neutral ceramidase secreted by endothelial cells is released in part associated with caveolin-1. | 1.41e-05 | 3 | 76 | 2 | 12921776 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 9533023 | ||
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 15225653 | ||
| Pubmed | Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA. | 1.41e-05 | 3 | 76 | 2 | 3427074 | |
| Pubmed | 1.41e-05 | 3 | 76 | 2 | 37169079 | ||
| Pubmed | 2.18e-05 | 257 | 76 | 6 | 16335952 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 2.59e-05 | 265 | 76 | 6 | 19240061 | |
| Pubmed | Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. | 2.82e-05 | 4 | 76 | 2 | 33547170 | |
| Pubmed | Localization of neutral ceramidase in caveolin-enriched light membranes of murine endothelial cells. | 2.82e-05 | 4 | 76 | 2 | 11591392 | |
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 10551839 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 30918250 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 31600785 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 20179351 | ||
| Pubmed | 4.69e-05 | 5 | 76 | 2 | 28090088 | ||
| Pubmed | Assembly and regulation of the membrane attack complex based on structures of C5b6 and sC5b9. | 7.03e-05 | 6 | 76 | 2 | 22832194 | |
| Pubmed | 7.03e-05 | 6 | 76 | 2 | 20616560 | ||
| Pubmed | HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism. | 7.03e-05 | 6 | 76 | 2 | 24778179 | |
| Pubmed | 7.39e-05 | 37 | 76 | 3 | 10531035 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 2294404 | ||
| Pubmed | ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via cGAS-STING. | 9.83e-05 | 7 | 76 | 2 | 30254094 | |
| Pubmed | Characterization of a mouse gene (Fbxw6) that encodes a homologue of Caenorhabditis elegans SEL-10. | 9.83e-05 | 7 | 76 | 2 | 11735228 | |
| Pubmed | Sequence organisation and transcriptional regulation of the mouse elastase II and trypsin genes. | 9.83e-05 | 7 | 76 | 2 | 3641189 | |
| Pubmed | CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers. | 9.83e-05 | 7 | 76 | 2 | 30552328 | |
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 24449837 | ||
| Pubmed | 9.83e-05 | 7 | 76 | 2 | 17525270 | ||
| Pubmed | VWF ADAMTS9 TAF1C ZNF197 ADGRB3 ETS2 ADAMTS8 HERC2 BACE2 GPRASP2 SEZ6L | 1.06e-04 | 1285 | 76 | 11 | 35914814 | |
| Pubmed | 1.08e-04 | 42 | 76 | 3 | 37353485 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 7987303 | ||
| Pubmed | 1.31e-04 | 8 | 76 | 2 | 21041365 | ||
| Pubmed | The secreted metalloprotease ADAMTS20 is required for melanoblast survival. | 1.31e-04 | 8 | 76 | 2 | 18454205 | |
| Pubmed | Molecular organization and function of the complement system. | 1.31e-04 | 8 | 76 | 2 | 3052276 | |
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 2.05e-04 | 52 | 76 | 3 | 24613359 | |
| Pubmed | 2.10e-04 | 10 | 76 | 2 | 11167130 | ||
| Pubmed | Systemwide disassembly and assembly of SCF ubiquitin ligase complexes. | 2.42e-04 | 55 | 76 | 3 | 37028429 | |
| Pubmed | 2.95e-04 | 985 | 76 | 9 | 12975309 | ||
| Pubmed | 3.07e-04 | 12 | 76 | 2 | 21946088 | ||
| Pubmed | Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners. | 3.07e-04 | 12 | 76 | 2 | 27100087 | |
| Pubmed | Systematic analysis and nomenclature of mammalian F-box proteins. | 3.29e-04 | 61 | 76 | 3 | 15520277 | |
| Pubmed | 3.62e-04 | 13 | 76 | 2 | 36379255 | ||
| Pubmed | 3.62e-04 | 13 | 76 | 2 | 21930703 | ||
| Pubmed | 3.62e-04 | 13 | 76 | 2 | 25802403 | ||
| Pubmed | 3.62e-04 | 13 | 76 | 2 | 37624694 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | GMNC CTTNBP2 TRIM25 BBX KLHL30 ADGRB1 XBP1 ALPK1 KAT14 IFNLR1 | 3.65e-04 | 1242 | 76 | 10 | 30973865 |
| Pubmed | 4.22e-04 | 14 | 76 | 2 | 26087183 | ||
| Pubmed | The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer. | 4.22e-04 | 14 | 76 | 2 | 27626314 | |
| Pubmed | Parallel ascending spinal pathways for affective touch and pain. | 4.22e-04 | 14 | 76 | 2 | 33116307 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 4.59e-04 | 163 | 76 | 4 | 23333304 | |
| Pubmed | Dynamic expression of chymotrypsin-like elastase 1 over the course of murine lung development. | 4.86e-04 | 15 | 76 | 2 | 24793170 | |
| Pubmed | Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. | 4.86e-04 | 15 | 76 | 2 | 20457761 | |
| Pubmed | 5.03e-04 | 167 | 76 | 4 | 22159717 | ||
| Pubmed | 5.54e-04 | 16 | 76 | 2 | 9851981 | ||
| Pubmed | Pdk1 activity controls proliferation, survival, and growth of developing pancreatic cells. | 5.54e-04 | 16 | 76 | 2 | 19635472 | |
| Pubmed | 5.54e-04 | 16 | 76 | 2 | 24727028 | ||
| Pubmed | 5.54e-04 | 16 | 76 | 2 | 28434801 | ||
| Pubmed | 5.99e-04 | 175 | 76 | 4 | 28071719 | ||
| Pubmed | Fbxo45 forms a novel ubiquitin ligase complex and is required for neuronal development. | 6.27e-04 | 17 | 76 | 2 | 19398581 | |
| Pubmed | 6.27e-04 | 17 | 76 | 2 | 10464288 | ||
| Pubmed | 6.27e-04 | 17 | 76 | 2 | 33084572 | ||
| Pubmed | 6.27e-04 | 17 | 76 | 2 | 22183742 | ||
| Pubmed | M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. | 7.05e-04 | 18 | 76 | 2 | 15070733 | |
| Pubmed | TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target. | 7.05e-04 | 18 | 76 | 2 | 34729304 | |
| Cytoband | 5p13 | 3.62e-04 | 17 | 76 | 2 | 5p13 | |
| Cytoband | 1q24 | 5.04e-04 | 20 | 76 | 2 | 1q24 | |
| Cytoband | 22q12.1 | 1.30e-03 | 32 | 76 | 2 | 22q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 1.62e-03 | 139 | 76 | 3 | chr5p13 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.47e-07 | 19 | 53 | 4 | 50 | |
| GeneFamily | ADAMTS like | 8.26e-07 | 7 | 53 | 3 | 947 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 2.52e-05 | 3 | 53 | 2 | 912 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.26e-03 | 161 | 53 | 4 | 593 | |
| GeneFamily | F-box and leucine rich repeat proteins | 1.71e-03 | 21 | 53 | 2 | 558 | |
| GeneFamily | Acyl-CoA synthetase family | 2.62e-03 | 26 | 53 | 2 | 40 | |
| GeneFamily | ETS transcription factor family | 3.04e-03 | 28 | 53 | 2 | 534 | |
| GeneFamily | Complement system|Sushi domain containing | 4.98e-03 | 36 | 53 | 2 | 492 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 THSD4 VWF SEMA5B ADAMTS9 PRSS12 SPON1 CELA2A ISM1 ADAMTS20 PAPLN ADAMTS8 CELA2B DMBT1 ADAMTSL3 FGL2 | 2.06e-08 | 1008 | 75 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS12 THSD4 VWF SEMA5B ADAMTS9 PRSS12 SPON1 CELA2A ISM1 ADAMTS20 PAPLN ADAMTS8 CELA2B DMBT1 ADAMTSL3 FGL2 | 2.64e-08 | 1026 | 75 | 16 | M5889 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS9 PRSS12 CELA2A ADAMTS20 ADAMTS8 CELA2B ADAMTSL3 | 4.10e-07 | 238 | 75 | 8 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS9 PRSS12 CELA2A ADAMTS20 ADAMTS8 CELA2B ADAMTSL3 | 4.66e-07 | 242 | 75 | 8 | MM17062 |
| Coexpression | INAMURA_LUNG_CANCER_SCC_DN | 6.30e-06 | 13 | 75 | 3 | M1255 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.84e-05 | 191 | 75 | 6 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.12e-05 | 196 | 75 | 6 | M3008 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 SEMA5B ADAMTS9 PRSS12 CELA2A ISM1 ADAMTS20 ADAMTS8 CELA2B ADAMTSL3 | 4.69e-05 | 738 | 75 | 10 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 SEMA5B ADAMTS9 PRSS12 CELA2A ISM1 ADAMTS20 ADAMTS8 CELA2B ADAMTSL3 | 5.42e-05 | 751 | 75 | 10 | M5885 |
| Coexpression | NABA_MATRISOME_HYPERPLASTIC_PANCREATIC_ISLETS | 5.58e-05 | 26 | 75 | 3 | MM17051 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_DN | 1.18e-04 | 267 | 75 | 6 | M13449 | |
| Coexpression | NABA_CORE_MATRISOME | 1.26e-04 | 270 | 75 | 6 | MM17057 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS | 1.26e-04 | 89 | 75 | 4 | M40280 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN | 1.29e-04 | 170 | 75 | 5 | M9445 | |
| Coexpression | NABA_CORE_MATRISOME | 1.39e-04 | 275 | 75 | 6 | M5884 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.12e-07 | 208 | 75 | 8 | gudmap_developingLowerUrinaryTract_adult_bladder_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 9.68e-07 | 149 | 75 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_1000 | CPEB2 MPZ VWF KLHL30 ASAH2 SPON1 IRAG1 BACE2 ADAMTSL3 TTLL7 FGL2 | 5.10e-05 | 734 | 75 | 11 | gudmap_developingLowerUrinaryTract_adult_bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_top-relative-expression-ranked_1000 | CPEB2 IL13RA2 KLHL30 DYNLT3 FBXW2 ADAMTS8 IRAG1 LCT ADAMTSL3 ENO3 TTLL7 | 7.06e-05 | 761 | 75 | 11 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000 |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-08 | 178 | 76 | 7 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-08 | 178 | 76 | 7 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.73e-08 | 182 | 76 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-08 | 183 | 76 | 7 | 5a936fb07074cec753bf19e3e3e52499605ea22c | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-08 | 183 | 76 | 7 | 07c18ccc45ddc9c22e482bd9ffb87f46ebcfe473 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.08e-08 | 193 | 76 | 7 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Goblet|World / Class top | 2.93e-07 | 157 | 76 | 6 | b352aa37d662629db6a9c6def9ee6d7c49a9071c | |
| ToppCell | Goblet-gob-1|World / Class top | 3.16e-07 | 159 | 76 | 6 | 62d4ca2b538382419252e306d7a789b64420fb18 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.36e-07 | 168 | 76 | 6 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-07 | 169 | 76 | 6 | bddb28a8b9afbe4a68f082e82caf96a6666fc674 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.52e-07 | 169 | 76 | 6 | 5ce46bac8e767feec7ecdc61689de225c49bd3f7 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.54e-07 | 175 | 76 | 6 | f6a6db992e803d36c866a91706b02f67e0fd3e09 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.54e-07 | 175 | 76 | 6 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.75e-07 | 181 | 76 | 6 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-07 | 181 | 76 | 6 | 75340f0c06977c88f9d2e56265f4aa84d706d2c6 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.97e-07 | 182 | 76 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 7.20e-07 | 183 | 76 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.20e-07 | 183 | 76 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.43e-07 | 184 | 76 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.67e-07 | 185 | 76 | 6 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.67e-07 | 185 | 76 | 6 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.67e-07 | 185 | 76 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 7.67e-07 | 185 | 76 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 7.67e-07 | 185 | 76 | 6 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.92e-07 | 186 | 76 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | Pericytes-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.17e-07 | 187 | 76 | 6 | 35f25780d113f60bf4c13749013c09612ee4ff41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.43e-07 | 188 | 76 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.24e-07 | 191 | 76 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 9.53e-07 | 192 | 76 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.82e-07 | 193 | 76 | 6 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-06 | 148 | 76 | 5 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 154 | 76 | 5 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 154 | 76 | 5 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 154 | 76 | 5 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 154 | 76 | 5 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5_FEZF2_DYRK2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.05e-06 | 160 | 76 | 5 | e2504c6deba4949a3a716a9ca68755f787bc0ae0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 9.07e-06 | 164 | 76 | 5 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_CYP26B1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.07e-06 | 164 | 76 | 5 | 902cfdb8155bb2773aa69826d5b3b810a39c8d34 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 9.35e-06 | 165 | 76 | 5 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-06 | 166 | 76 | 5 | 01544c851588f1cde05d6700c3d1167f70a0fbd5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-06 | 166 | 76 | 5 | c22a97353f7eb084f768c13d7767a80b30f05043 | |
| ToppCell | Club-club-2|World / Class top | 9.62e-06 | 166 | 76 | 5 | 56f11efb6b686b3ee2c34a051f626e3d761b5112 | |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.62e-06 | 166 | 76 | 5 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 169 | 76 | 5 | db73dae011ff3749b3706e50ab46d03b775dd6bb | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 169 | 76 | 5 | 97b7047b87ce0052d8580565c9b44fd2aa6f0d5c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-05 | 169 | 76 | 5 | 1a684471dbda42e1470e5a889648666e14f25982 | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.05e-05 | 169 | 76 | 5 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_RSAD2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 170 | 76 | 5 | 63dfbc4746717132dc81b6bac868c7498fc96283 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.11e-05 | 171 | 76 | 5 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-05 | 174 | 76 | 5 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 175 | 76 | 5 | bc6bd8c3ce956245ef4db91af9501649d5c09478 | |
| ToppCell | (03)_Secretory|World / shred by cell type and Timepoint | 1.28e-05 | 176 | 76 | 5 | cb7b1945788196ca79007f0768b6576ec885a0e5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.31e-05 | 177 | 76 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-05 | 177 | 76 | 5 | 4553ee8cd9c24db6511b09fe49ed11a89e7cde9e | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 178 | 76 | 5 | 07d6d5275a4d17f8024fde74e92ab2505b4adfbf | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 179 | 76 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.46e-05 | 181 | 76 | 5 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 1.46e-05 | 181 | 76 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-05 | 181 | 76 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.46e-05 | 181 | 76 | 5 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 182 | 76 | 5 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 182 | 76 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 182 | 76 | 5 | 94e70746e35a3062015d4b83ee545f4f84f47420 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 182 | 76 | 5 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 183 | 76 | 5 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 183 | 76 | 5 | 99ab7a43527eb226027efbcd8c0b6a8e46fc3c93 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 1.54e-05 | 183 | 76 | 5 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 183 | 76 | 5 | 28916f0597690ff534578be2cb715b485cb1de1a | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.58e-05 | 184 | 76 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | e29079ef09aee62c3e9756341db4e59ca9dbf7ac | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 185 | 76 | 5 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.62e-05 | 185 | 76 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | facs-Large_Intestine-Distal-24m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 185 | 76 | 5 | 2ecc4b76b3645b65c226c2298bff307cc6479172 | |
| ToppCell | LV-07._Pericyte|LV / Chamber and Cluster_Paper | 1.62e-05 | 185 | 76 | 5 | acb38eba871ec72f2a8136a33b87d33b8c85465d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 186 | 76 | 5 | 32d30f08b20a0a28e38b37bd52ab26d1d43736ce | |
| ToppCell | RV-07._Pericyte|RV / Chamber and Cluster_Paper | 1.67e-05 | 186 | 76 | 5 | c533b264fbe12bc35467486fc7fbde24ba968fe1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.71e-05 | 187 | 76 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 1.71e-05 | 187 | 76 | 5 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 187 | 76 | 5 | a63fa3255ad58f3a73c596df99ce9649fdbaeb39 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 187 | 76 | 5 | b1bb5c48258a9d058614d23001899dbe44857a1f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.71e-05 | 187 | 76 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 188 | 76 | 5 | bfd3b4f57785596b2bd2c657e0d2d8b0f40ba36d | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 188 | 76 | 5 | c300accbac71a3bc075fe985543d8a8ead82531b | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 188 | 76 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 188 | 76 | 5 | 794fc1d9a726945c42f7eac221eed938309b47a9 | |
| ToppCell | facs-Large_Intestine-Distal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-05 | 190 | 76 | 5 | 3964a8390522b61b73235151bb0a2ff36b856867 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.85e-05 | 190 | 76 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 190 | 76 | 5 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 190 | 76 | 5 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 191 | 76 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 191 | 76 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.89e-05 | 191 | 76 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.94e-05 | 192 | 76 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 192 | 76 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.94e-05 | 192 | 76 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-05 | 193 | 76 | 5 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 193 | 76 | 5 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 193 | 76 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 193 | 76 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 193 | 76 | 5 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.69e-06 | 227 | 74 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | 4-hydroxyphenylacetylglutamine measurement | 1.86e-05 | 3 | 74 | 2 | EFO_0800688 | |
| Disease | brain measurement, neuroimaging measurement | THSD4 GMNC CTTNBP2 ADAMTS9 ADAMTS20 KIAA1755 SLC12A8 ADAMTS8 | 7.09e-05 | 550 | 74 | 8 | EFO_0004346, EFO_0004464 |
| Disease | indoleacetylglutamine measurement | 9.25e-05 | 6 | 74 | 2 | EFO_0800035 | |
| Disease | cortical thickness | THSD4 GMNC CTTNBP2 ADAMTS9 PRSS12 ADAMTS20 KIAA1755 SLC12A8 ADAMTS8 IRAG1 ADAMTSL3 | 9.92e-05 | 1113 | 74 | 11 | EFO_0004840 |
| Disease | underweight body mass index status | 2.21e-04 | 9 | 74 | 2 | EFO_0005936 | |
| Disease | t-tau measurement | 2.89e-04 | 126 | 74 | 4 | EFO_0004760 | |
| Disease | Bipolar I disorder | 3.36e-04 | 11 | 74 | 2 | C0853193 | |
| Disease | brain connectivity measurement | 5.09e-04 | 400 | 74 | 6 | EFO_0005210 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 5.54e-04 | 14 | 74 | 2 | EFO_0004736, GO_0031427 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 7.28e-04 | 16 | 74 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | urate measurement, bone density | 9.23e-04 | 619 | 74 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | skin sensitivity to sun | 1.03e-03 | 19 | 74 | 2 | EFO_0004795 | |
| Disease | Glioma | 1.38e-03 | 87 | 74 | 3 | C0017638 | |
| Disease | neuroimaging measurement | THSD4 GMNC CTTNBP2 PRSS12 ADAMTS20 KIAA1755 SLC12A8 ROBO3 IRAG1 | 1.39e-03 | 1069 | 74 | 9 | EFO_0004346 |
| Disease | glioblastoma (is_implicated_in) | 1.65e-03 | 24 | 74 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | cerebrospinal fluid biomarker measurement | 1.83e-03 | 96 | 74 | 3 | EFO_0006794 | |
| Disease | cortical surface area measurement | THSD4 GMNC CTTNBP2 ADAMTS9 PRSS12 ADAMTS20 KIAA1755 SLC12A8 IRAG1 ADAMTSL3 | 1.89e-03 | 1345 | 74 | 10 | EFO_0010736 |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.12e-03 | 101 | 74 | 3 | EFO_0004530, EFO_0007878 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.36e-03 | 105 | 74 | 3 | DOID:9352 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FWTGSQLACWTNSET | 336 | Q9Y5Z0 | |
| HEGCWNEESWTFSQS | 651 | Q8WY36 | |
| TQTEGAKADGSWSCW | 531 | P07357 | |
| AKADGSWSCWSSWSV | 536 | P07357 | |
| NEWSSWSACSASCSQ | 471 | O14514 | |
| ESGVEEWSQWSTCSV | 291 | O60242 | |
| EWSQWSTCSVTCGQG | 296 | O60242 | |
| WSSWSQCSVTCSNGT | 406 | O60242 | |
| WVLGDWSECSSTCGA | 836 | Q9UP79 | |
| ATSTSWQIVCNDASW | 86 | P0C7U1 | |
| VDYATCSSSAWWGSS | 181 | P08217 | |
| SDWTVGNWSECSVSC | 946 | P58397 | |
| NCNEFSCPSWAASEW | 1016 | P59510 | |
| SWKANSWNECSVTCG | 1476 | P59510 | |
| SAWSNLSGFSSSASW | 581 | Q96QP1 | |
| SWSSVIGVWYSESTS | 111 | P54107 | |
| WQCTNGSEVQSSWAE | 111 | Q14627 | |
| GSRSAWAVEFFASWC | 56 | O00391 | |
| GTKTDTWSTTQAWCF | 336 | Q0D2K2 | |
| SSDFWNLDWSSACSC | 476 | Q5KSL6 | |
| WGTVCSSHWDDSDAS | 191 | P56730 | |
| SAWDSSDRSWASTVD | 381 | Q8IU57 | |
| AQSFAWSSCSEWSIG | 771 | O95714 | |
| CAVSGGSISSSNWWS | 41 | A0A075B6R2 | |
| STTEGAWEAPWCTVS | 596 | Q5JYT7 | |
| ATSTSWQIVCNDASW | 701 | Q9NR71 | |
| WFAGCTNRTWNSSAV | 186 | Q9H9K5 | |
| STCSAAQRDSWWSSG | 881 | Q9Y6F6 | |
| KSCQSFISWTGDGWE | 376 | P15036 | |
| STWWSTVAGCLSVGS | 171 | Q9H8E8 | |
| TSCTLDWWLAQASVG | 181 | Q6U736 | |
| ALLSFSCWGSDWESD | 11 | P09848 | |
| SCWGSDWESDRNFIS | 16 | P09848 | |
| HGDIFEWCATSWLTS | 186 | Q9Y2T5 | |
| EWCATSWLTSAYFTG | 191 | Q9Y2T5 | |
| HDAAWSTGPWSSCSV | 1441 | Q9P2N4 | |
| SCCTTQLFASSWGWQ | 1281 | Q14674 | |
| WGSDSLQDSWCTAAG | 221 | Q7Z5Q1 | |
| VDYATCSSSGWWGST | 181 | P08218 | |
| GQWGCWSSWSTCDAT | 566 | P13671 | |
| SDGWWSLEDVTCNNT | 1026 | Q8WZ74 | |
| GSEFWADGTCSQWCR | 4421 | Q9Y6R7 | |
| TESTLWSCTKNSWGH | 491 | Q9UEW3 | |
| SSGWWFDACLSANLN | 376 | Q14314 | |
| WDTTSDGTCTVRWEN | 86 | P51808 | |
| FDQDDWATWTSFLSG | 296 | P13929 | |
| TDISDSAFDSWSWLG | 366 | Q9UKA1 | |
| SAFDSWSWLGCCQSL | 371 | Q9UKA1 | |
| CTAWDSWSGASQTLG | 96 | O00321 | |
| TGSFDNTVACWEWSS | 201 | Q9UKT8 | |
| GSWGTVCDDSWDTND | 121 | Q9UGM3 | |
| GSWGTVCDDSWDTND | 621 | Q9UGM3 | |
| GSWGTVCDDSWDTSD | 881 | Q9UGM3 | |
| QGSWGTVCDDSWDTN | 1011 | Q9UGM3 | |
| ASWEGQESCWNKQTS | 526 | A0AV02 | |
| STDGEGDWSLWSVCS | 216 | B1AKI9 | |
| QFSSIWWDDSGACRV | 111 | Q9UBD0 | |
| FIWTCDDASSNTWSP | 241 | P55735 | |
| SNWSPWSACSSSTCD | 446 | Q9HCB6 | |
| GSDTLTCQWDLSWSS | 781 | Q9BYH1 | |
| VDVSTETWVSFWAAG | 31 | A6NCL1 | |
| ASWTSQDTAGCSQWL | 626 | Q15572 | |
| WGCIVSSVWSSSNVA | 26 | Q9HDB5 | |
| WSGSEDEASNPFSFW | 281 | Q96D09 | |
| AFWTTWTQSCSSNAL | 206 | P17861 | |
| NWGSDFLCTEWKASN | 1066 | Q6P1J6 | |
| DSGWCQTFDFITAAW | 176 | Q96LB1 | |
| DVSWCLSDSGWIVAT | 261 | Q08AH1 | |
| SDTGWAKSAWSSVFS | 276 | Q53FZ2 | |
| DLSSNVATSFTWGWD | 11 | Q13309 | |
| VATSFTWGWDSSKTS | 16 | Q13309 | |
| ASCWATGWDQDTSDA | 156 | Q2L4Q9 | |
| WGTSFQGSSSSVWET | 26 | O14709 | |
| TYAWSVENSSTDSWV | 176 | P40200 | |
| DFANSWALSSGEQWC | 186 | P04275 | |
| FSWSHGSWSDCSAEC | 306 | O95428 | |
| CVAKSSTGEATWSGW | 521 | Q96MS0 | |
| SASWCVEWFNTKISA | 546 | Q14258 | |
| FICNECGKSFTWWSS | 281 | Q96BV0 | |
| WSEWSKCTDDGAQSR | 971 | Q9P283 | |
| EYWCQCVAWSSSGTT | 121 | Q6ZN44 | |
| FDWKSSCETWSVAFS | 21 | Q9NYS7 | |
| SCETWSVAFSPDGSW | 26 | Q9NYS7 | |
| TGKVEWFAGSWSQCS | 851 | Q6ZMP0 | |
| WFAGSWSQCSIECGS | 856 | Q6ZMP0 | |
| CNSSSLTENVWDESW | 351 | Q9NYI0 | |
| GLWNCFCDSGSSWES | 781 | Q6ZT98 | |
| RWFTSVWSQCSVSCG | 1486 | P82987 | |
| VTLHCSFWSSEWVSD | 46 | P25189 | |
| SFWSSEWVSDDISFT | 51 | P25189 |